Hier befinden Sie sich auf der Publikationsseite des Entwicklungsbiologischen Labors.
Alle Publikationen ab 2006 in Zeitschriften mit Impact-Faktor finden Sie außerdem in unserer Publikationsdatenbank, insbesondere auch eine Übersicht über aktuelle, hochrangige Publikationen.
Becker, K., El-Faddagh, M., Schmidt, M.H. & Laucht, M. (2007). Is the serotonin transporter polymorphism (5-HTTLPR) associated with harm avoidance and internalising problems in childhood and adolescence? Journal of Neural Transmission, 114: 395-402
Laucht, M., Becker, K., Blomeyer, D. & Schmidt, M.H. (2006) Novelty seeking involved in mediating the association between the DRD4 exon III polymorphism and heavy drinking in male adolescents: Results from a high-risk community sample. Biological Psychiatry 61: 87-92
Laucht M, Becker K, Schmidt MH (2006) Visual exploratory behaviour in infancy and novelty seeking in adolescence: two developmentally specific phenotypes of DRD4? Journal of Child Psychology and Psychiatry 47 (11):1143-1151
Skowronek MH, Laucht M, Hohm E, Becker K, Schmidt MH (2006) Interaction between the dopamine D4 receptor and the serotonin transporter promoter polymorphisms in alcohol and tobacco use among 15-year-olds. Neurogenetics 7:239-246
Vogel CIG, Laucht M, Furtado EF, Becker K, Schmidt MH (2006) Association of DRD4 exon III polymorphism with auditory P300 amplitude in 8-year-old children. Journal of Neural Transmission 113:1935-1941
Becker K, Laucht M, El-Faddagh M, Schmidt MH (2005) The dopamine D4 receptor gene exon III polymorphism is associated with novelty seeking in 15-year-old males from a high risk community sample. Journal of Neural Transmission, 112, 857-858
Laucht M, Becker K, El-Faddagh M, Hohm E, Schmidt MH (2005) Association of the DRD4 exon III polymorphism with smoking in 15-year-olds: a mediating role for novelty seeking? Journal of the American Academy of Child and Adolescent Psychiatry, 44, 477-484
El-Faddagh M, Laucht M, Maras A, Vöhringer L, Schmidt MH (2004) Association of DRD4 with ADHD in a community sample of children at risk for psychopathology: a longitudinal study from birth to 11 years of age. Journal of Neural Transmission, 111, 883-889
El-Faddagh M, Schloss P, Ristow G, Becker K, Holtmann M, Schmidt MH (2003) Untersuchung zur Nonresponse auf Methylphenidat bei Kindern mit hyperkinetischer Störung. in : U. Lehmkuhl (eds) "Seelische Krankheit im Kindes- und Jugendalter- Wege zur Heilung", DGKJPP-Kongress 2002, Vandenhoeck & Ruprecht, Göttingen
Seeger G, Schloss P, Schmidt MH (2001) Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders. Mol Psychiatry 6:235-8
Seeger G, Schloss P, Schmidt MH (2001) Marker gene polymorphisms in hyperkinetic disorder-predictors of clinical response to treatment with methylphenidate? Neurosci Lett 313:45-8
|
